• News
    • Latest news
    • News search
    • Health
    • Finance
    • Food
    • Career news
    • Content series
    • Try Devex Pro
  • Jobs
    • Job search
    • Post a job
    • Employer search
    • CV Writing
    • Upcoming career events
    • Try Career Account
  • Funding
    • Funding search
    • Funding news
  • Talent
    • Candidate search
    • Devex Talent Solutions
  • Events
    • Upcoming and past events
    • Partner on an event
  • Post a job
  • About
      • About us
      • Membership
      • Newsletters
      • Advertising partnerships
      • Devex Talent Solutions
      • Contact us
Join DevexSign in
Join DevexSign in

News

  • Latest news
  • News search
  • Health
  • Finance
  • Food
  • Career news
  • Content series
  • Try Devex Pro

Jobs

  • Job search
  • Post a job
  • Employer search
  • CV Writing
  • Upcoming career events
  • Try Career Account

Funding

  • Funding search
  • Funding news

Talent

  • Candidate search
  • Devex Talent Solutions

Events

  • Upcoming and past events
  • Partner on an event
Post a job

About

  • About us
  • Membership
  • Newsletters
  • Advertising partnerships
  • Devex Talent Solutions
  • Contact us
  • My Devex
  • Update my profile % complete
  • Account & privacy settings
  • My saved jobs
  • Manage newsletters
  • Support
  • Sign out
Latest newsNews searchHealthFinanceFoodCareer newsContent seriesTry Devex Pro
    • News
    • Safety First: Sponsored by BD

    Protecting cancer carers: Reducing the risk of hazardous drugs in oncology

    More than half of all hazardous drugs are products used to treat cancer. Potential side effects include hair loss, infertility, and spontaneous abortions. Oncology nurses on the front-line are at high risk, so how should they be better protected?

    By Devex Editor // 15 February 2021
    Oncology nurses on the front-line are at high risk from using hazardous drugs to treat cancer patients. How should they be better protected?

    The coronavirus pandemic has highlighted the importance of health worker safety, with medical staff finding it difficult to procure sufficient personal protective equipment and other medical protection equipment to help them treat COVID-19 patients safely.

    But with more than 30 million people predicted to be diagnosed with cancer by 2040, up from an estimated 20 million in 2020, oncology nurses continue to be exposed to the potentially dangerous side effects — including hair loss, infertility, miscarriages, and increased risk of leukemia to name a few — from using hazardous drugs to treat cancer patients.

    While tangible progress has been made in some countries, such as legislation, training and education, and provision of equipment to minimize exposure, the situation in many low- to middle-income nations remains grim.

    Mary Moyo (not her real name), a Zimbabwean nurse who works in the only cancer center in the country, has been working in suboptimal conditions for years. “All I can do to protect myself is spend as little time as possible in drug preparation rooms,” Moyo said.

    Meanwhile, Jimvert Camarillo, head nurse at Perpetual Help Medical Center, explained how in practice, it was difficult to adhere to international standards to handle hazardous drugs in the Philippines, but advocated for more training and education as one way of improving the situation. “[S]afe handling begins with education,” he said. “[W]e must train our oncology nurses, what are the effects of these hazardous agents, how can we prevent this exposure, what are the barriers, how can we dispose of this hazardous agent.”

    Read the full visual story on protecting cancer carers.

    For more coverage on health worker and patient safety, visit the Safety First series. Join the conversation using the hashtags #HCWSafety and #PatientSafety.

    • Global Health
    Printing articles to share with others is a breach of our terms and conditions and copyright policy. Please use the sharing options on the left side of the article. Devex Pro members may share up to 10 articles per month using the Pro share tool ( ).

    About the author

    • Devex Editor

      Devex Editor

      Thanks for reading and for your interest in Devex. Sponsored content is produced in collaboration between Devex’s partnerships editorial team and our partners to promote a partner’s work or perspective on a particular issue. It gives actors across the global development sector — including nongovernmental organizations, private sector stakeholders, aid agencies and government institutions — the opportunity to go beyond traditional advertising and tell their stories in an impactful way. If you'd like to learn more about how you can shine a spotlight on a particular issue with Devex, please email advertising@devex.com. We look forward to hearing from you.

    Search for articles

    Most Read

    • 1
      The power of diagnostics to improve mental health
    • 2
      Lasting nutrition and food security needs new funding — and new systems
    • 3
      Opinion: Urgent action is needed to close the mobile gender gap
    • 4
      The UN's changing of the guard
    • 5
      The top local employers in Europe
    • News
    • Jobs
    • Funding
    • Talent
    • Events

    Devex is the media platform for the global development community.

    A social enterprise, we connect and inform over 1.3 million development, health, humanitarian, and sustainability professionals through news, business intelligence, and funding & career opportunities so you can do more good for more people. We invite you to join us.

    • About us
    • Membership
    • Newsletters
    • Advertising partnerships
    • Devex Talent Solutions
    • Post a job
    • Careers at Devex
    • Contact us
    © Copyright 2000 - 2025 Devex|User Agreement|Privacy Statement